Introduction
============

Activation of T-lymphocytes via the T cell receptor/CD3 (TCR/CD3) complex results in multiple intracellular signaling pathways ([Kennedy et al. 1999](#Kennedyetal1999){ref-type="bib"}). Among these pathways, an elevation of \[Ca^2+^\]~i~ (intracellular Ca^2+^-concentration) is essential for proliferation and clonal expansion (reviewed in [Guse 1998](#Guse1998){ref-type="bib"}). The increase of \[Ca^2+^\]~i~ in T cells consists of calcium release from intracellular stores, and, as a major source for the long-lasting Ca^2+^-signal observed in T cells, subsequent entry of calcium through specific calcium channels in the plasma membrane (reviewed in [Guse 1998](#Guse1998){ref-type="bib"}). Ca^2+^-release is activated by the calcium mobilizing second messengers [d]{.smallcaps}-*myo*-inositol 1,4,5-trisphosphate(Ins(1,4,5)P~3~) and cyclic ADP-ribose (cADPR). Recent work indicates that Ins(1,4,5)P~3~ primarily acts during the initial phase of Ca^2+^-signaling in T cells, whereas cADPR is essentially involved in the sustained phase of Ca^2+^-signaling ([Guse et al. 1999](#Guseetal1999){ref-type="bib"}).

Besides Ins(1,4,5)P~3~ and cADPR, another Ca^2+^-mobilizing natural compound, nicotinic acid adenine dinucleotide phosphate (NAADP^+^) was introduced ([Chini et al. 1995](#Chinietal1995){ref-type="bib"}; [Lee and Aarhus 1995](#LeeandAarhus1995){ref-type="bib"}). NAADP^+^ was originally discovered as a contaminant of commercial nicotinamide adenine dinucleotide phosphate (NADP^+^) preparations; such preparations could also be enriched in NAADP^+^ content by alkaline treatment ([Clapper et al. 1987](#Clapperetal1987){ref-type="bib"}). Very low concentrations of NAADP^+^ in the range of 10--50 nM were shown to effectively release Ca^2+^ from intracellular stores of selected invertebrate and mammalian cell types, such as sea urchin eggs ([Lee and Aarhus 1995](#LeeandAarhus1995){ref-type="bib"}), ascidian oocytes ([Albrieux et al. 1998](#Albrieuxetal1998){ref-type="bib"}), and mouse pancreatic acinar cells ([Cancela et al. 1999](#Cancelaetal1999){ref-type="bib"}). NAADP^+^-mediated Ca^2+^-release was not sensitive to the cADPR antagonist, 8-NH~2~-cADPR; the Ins(1,4,5)P~3~ antagonist, heparin ([Lee and Aarhus 1995](#LeeandAarhus1995){ref-type="bib"}); or to the antagonists of ryanodine receptors (RyR), procaine or ruthenium red ([Chini et al. 1995](#Chinietal1995){ref-type="bib"}). Together, with the lack of cross-desensitization observed between the NAADP^+^/Ca^2+^-release system on one hand, and the cADPR/- or the Ins(1,4,5)P~3~/Ca^2+^-release systems on the other hand ([Chini et al. 1995](#Chinietal1995){ref-type="bib"}; [Lee and Aarhus 1995](#LeeandAarhus1995){ref-type="bib"}), these data indicate that the NAADP^+^-dependent Ca^2+^-release system is different from the two others. Although the receptor for NAADP^+^ has not yet been identified, unspecific effects of NAADP^+^ are largely unlikely since concrete structural requirements for NAADP^+^-mediated Ca^2+^-release were demonstrated in sea urchin eggs, e.g., the NH~2~-group at position 6 of the adenine ring or the phosphate group at the 2′-position of the ribose are necessary ([Lee and Aarhus 1997](#LeeandAarhus1997){ref-type="bib"}). The latter can be replaced by a 3′-phosphate or a 2′,3′-cyclic phosphate, but this alteration resulted in a weaker Ca^2+^-release activity ([Lee and Aarhus 1997](#LeeandAarhus1997){ref-type="bib"}). Further characteristic properties of NAADP^+^-mediated Ca^2+^-release in sea urchin eggs are a unique self inactivation or self desensitization process ([Aarhus et al. 1996](#Aarhusetal1996){ref-type="bib"}; [Genazzani et al. 1996](#Genazzanietal1996){ref-type="bib"}), and Ca^2+^-release from a thapsigargin-insensitive Ca^2+^-pool ([Genazzani and Galione 1996](#GenazzaniandGalione1996){ref-type="bib"}).

The fact that recent reports indicated a role for NAADP^+^ in Ca^2+^-signaling of mammalian cells ([Bak et al. 1999](#Baketal1999){ref-type="bib"}; [Cancela et al. 1999](#Cancelaetal1999){ref-type="bib"}) prompted us to study its effects in human Jurkat T cells. We report here that NAADP^+^ specifically and dose-dependently stimulated Ca^2+^-signaling when microinjected into intact Jurkat T cells. Furthermore, we show that self inactivation of the NAADP^+^/Ca^2+^-release system almost completely inhibited Ins(1,4,5)P~3~- or cADPR-mediated Ca^2+^-signaling. Most importantly, we demonstrate that self inactivation of the NAADP^+^/Ca^2+^-release also completely antagonized Ca^2+^-signaling mediated by ligation of the TCR/CD3-complex.

Materials and Methods
=====================

Reagents
--------

cADPR, 8-OCH~3~-cADPR, and [d]{.smallcaps}-*myo*-inositol 1,4,6-trisphosphorothioate (Ins(1,4,6)PS~3~) were synthesized exactly as described ([Ashamu et al. 1995](#Ashamuetal1995){ref-type="bib"}; [Murphy et al. 2000](#Murphyetal2000){ref-type="bib"}), purified by anion-exchange chromatography on Q-Sepharose, and used as their triethylammonium salts. Purity of ligands was assessed by ^1^H and ^31^P NMR spectroscopy, mass spectroscopy, and, when appropriate, HPLC. NAADP^+^ and NADP^+^ were purchased from Sigma-Aldrich. The purity of NAADP^+^ was described by the manufacturer to be ∼95%; this was confirmed by reverse phase HPLC using the method of da [Silva et al. 1998](#Silvaetal1998){ref-type="bib"}. Fura 2/AM was obtained from Calbiochem. Anti-CD3 mAb OKT3 was purified from hybridoma supernatant on protein G--Sepharose.

Cell Culture
------------

Jurkat T lymphocytes (subclone JMP) were cultured in RPMI 1640 medium containing the following additions: glutamax I, Hepes (20 mM, pH 7.4), NCS (7.5%), penicillin (100 U/ml), and streptomycin (50 μg/ml; all obtained from Life Technologies). The cells were cultured at 37°C in a humidified atmosphere in the presence of 5% CO~2~.

Ratiometric Ca^2+^ Imaging
--------------------------

Batches of 10^7^ Jurkat T cells were loaded with Fura2/AM as described ([Guse et al. 1993](#Guseetal1993){ref-type="bib"}). Fura2-loaded cells (10^7^ cells/5 ml) were kept at room temperature until use. Glass coverslips were coated first with BSA (5 mg/ml), and then with poly-[l]{.smallcaps}-lysine (0.1 mg/ml). Small chambers consisting of a rubber O-ring were sealed on the coverslips by silicon grease. Then, 90 μl of extracellular buffer (140 mM NaCl, 5 mM KCl, 1 mM MgSO~4~, 1 mM CaCl~2~, 20 mM Hepes, 1 mM NaH~2~PO~4~, 5.5 mM glucose, pH 7.4) was added, followed by addition of 10 μl cell suspension. The coverslip was mounted on the stage of an inverted microscope (Axiovert 100, ZEISS). Ratiometric Ca^2+^ imaging was performed using a PhotoMed/Photon Technology (Wedel) digital imaging system built around the Axiovert 100 microscope. Illumination at 340 and 380 nm was carried out using a chopper/optical filter system. Images were captured by an intensified CCD camera (type C2400-77; spatial resolution: 525 × 487 pixel; Hamamatsu) and stored as individual 340 and 380 images on hard disk. Sampling rate was usually 5 s for a pair of images (340 and 380 nm) using 100-fold magnification. Data analysis was performed off-line using PhotoMed/Photon Technology (Wedel) Image master analysis software. Ratio images (340/380) were constructed pixel by pixel, and changes in the ratio over time were measured by applying regions-of-interest on individual cells. Finally, ratio values were converted to Ca^2+^-concentrations by external calibration.

Microinjection Experiments
--------------------------

Parallel Ca^2+^ imaging and microinjection experiments require a firm attachment of the Jurkat T cells without preactivation of intracellular Ca^2+^-signaling. This was achieved by the above mentioned coating procedure of the glass coverslips, as detailed earlier ([Guse et al. 1997](#Guseetal1997){ref-type="bib"}). The cells were kept in a small chamber (100 μl vol) in extracellular buffer (140 mM NaCl, 5 mM KCl, 1 mM MgSO~4~, 1 mM CaCl~2~, 20 mM Hepes, 1 mM NaH~2~PO~4~, 5.5 mM glucose, pH 7.4). Compounds to be microinjected were cleared from particles by either filtration through 0.45-μm filters, by centrifugation in an Eppendorf centrifuge at maximal speed for 10 min, or by both. Femtotips II (Eppendorf) were filled with 5 μl of reagent solution and inserted into the semiautomatic microinjection system (Transjector 5246, Micromanipulator 5171, Eppendorf). Injection parameters were: injection pressure, 80 hPa; compensatory pressure, 40 hPa; duration of injection. 0.5 s; velocity of pipette, 700 μm/s; pipette angle, 45°. Injections were performed into the upper part of the cell.

Results
=======

Microinjection of NAADP^+^ at a pipette concentration as low as 10 nM stimulated repetitive, long-lasting Ca^2+^-spiking of low amplitude in intact Jurkat T cells, whereas injection of intracellular buffer alone had no effect ([Fig. 1A](#F1){ref-type="fig"}, [Fig. B](#F1){ref-type="fig"}, [Fig. E](#F1){ref-type="fig"}, and [Fig. F](#F1){ref-type="fig"}). Microinjection of 0.1 or 1 nM NAADP^+^ was without effect in most of the cells ([Fig. 1C](#F1){ref-type="fig"} and [Fig. D](#F1){ref-type="fig"}, and data not shown). At a pipette concentration of 50 nM NAADP^+^, an initial, rapidly occurring Ca^2+^-peak with a high amplitude was observed which turned into gradually lowering oscillations during the first 350--400 s. After this time period, the calcium response changed into a low, but sustained, plateau phase with very small oscillations ([Fig. 1G](#F1){ref-type="fig"} and [Fig. H](#F1){ref-type="fig"}). At pipette concentrations of 100 nM and 1 μM, similar responses were observed ([Fig. 1](#F1){ref-type="fig"}, I--L). However, the peak amplitude of the initial Ca^2+^-spike declined with increasing NAADP^+^ concentrations ([Fig. 1J](#F1){ref-type="fig"} and [Fig. L](#F1){ref-type="fig"}), and the decay of the Ca^2+^-signal was accelerated ([Fig. 1](#F1){ref-type="fig"} H, J, and L). At 10 μM NAADP^+^, the Ca^2+^-response appeared similar to the one at 1 nM ([Fig. 1M](#F1){ref-type="fig"} and [Fig. N](#F1){ref-type="fig"}), whereas at 100 μM NAADP^+^, no signal was detectable ([Fig. 1O](#F1){ref-type="fig"}). The dose response relationship shows a bell-shaped curve for the initial Ca^2+^-peak with an optimal NAADP^+^ concentration at 100 nM ([Fig. 2](#F2){ref-type="fig"} A). However, only minor changes of the long-lasting Ca^2+^-signal as measured at 400 s were observed in response to 100 nM NAADP^+^ ([Fig. 2](#F2){ref-type="fig"} B). These data indicate that, similar to the few other cellular systems investigated so far ([Chini et al. 1995](#Chinietal1995){ref-type="bib"}; [Lee and Aarhus 1995](#LeeandAarhus1995){ref-type="bib"}; [Albrieux et al. 1998](#Albrieuxetal1998){ref-type="bib"}; [Cancela et al. 1999](#Cancelaetal1999){ref-type="bib"}), NAADP^+^ at low nanomolar concentrations activates Ca^2+^-signaling in T cells, whereas micromolar concentrations of NAADP^+^ rapidly cause self inactivation of the Ca^2+^-release system.

The high initial Ca^2+^-spike observed after microinjection of 50 nM NAADP^+^ was massively reduced when the extracellular Ca^2+^-concentration was decreased to a nominal Ca^2+^-free buffer, indicating that Ca^2+^-entry is involved in the NAADP^+^-mediated Ca^2+^-response (data not shown).

To prove the specificity of the effect of NAADP^+^ on intracellular Ca^2+^-signaling in T cells, NADP^+^ was used in parallel microinjection experiments. NADP^+^ is a structurally similar molecule, bearing a nicotinamide group instead of the nicotinic acid group. In contrast to NAADP^+^, microinjection of NADP^+^ (50 nM) was completely without effect on Ca^2+^-signaling ([Fig. 3A](#F3){ref-type="fig"} and [Fig. B](#F3){ref-type="fig"}).

The Ca^2+^-release system that is targeted by NAADP^+^ has not yet been identified, but work in other cell systems indicates that neither the Ins(1,4,5)P~3~ receptor (InsP3-R) nor the RyR are involved ([Chini et al. 1995](#Chinietal1995){ref-type="bib"}; [Lee and Aarhus 1995](#LeeandAarhus1995){ref-type="bib"}). However, both of these classical intracellular Ca^2+^-release systems have been demonstrated to be essential parts of the Ca^2+^-signaling machinery of T cells ([Jayaraman et al. 1995](#Jayaramanetal1995){ref-type="bib"}; [Guse et al. 1999](#Guseetal1999){ref-type="bib"}). Thus, the next series of experiments was designed to investigate potential interrelations between the NAADP^+^ system on one hand and both the Ins(1,4,5)P~3~ and cADPR systems on the other.

The specific cADPR antagonist 8-OCH~3~-cADPR ([Guse et al. 1999](#Guseetal1999){ref-type="bib"}), when coinjected with an optimal NAADP^+^ concentration, did not significantly affect NAADP^+^-mediated Ca^2+^-signaling ([Fig. 4A](#F4){ref-type="fig"} and [Fig. F](#F4){ref-type="fig"} vs. B and G). However, when a self-desensitizing concentration of NAADP^+^ (10 μM) was coinjected with a stimulating concentration of cADPR (10 μM), a massive decrease of the cADPR-mediated Ca^2+^-signal was observed ([Fig. 4C](#F4){ref-type="fig"} and [Fig. H](#F4){ref-type="fig"} vs. E and J). On the other hand, an optimal stimulating concentration of NAADP^+^ (50 nM) microinjected together with cADPR (10 μM) did not significantly change the Ca^2+^-signals ([Fig. 4D](#F4){ref-type="fig"} and [Fig. I](#F4){ref-type="fig"} vs. E and J). These data indicate that a functional, nondesensitized NAADP^+^/Ca^2+^-release system is necessary for cADPR-mediated Ca^2+^-release.

The specific Ins(1,4,5)P~3~ antagonist, Ins(1,4,6)PS~3~ ([Guse et al. 1997](#Guseetal1997){ref-type="bib"}; [Murphy et al. 2000](#Murphyetal2000){ref-type="bib"}), was also coinjected with an optimal NAADP^+^ concentration. Surprisingly, there was a partial reduction of the initial Ca^2+^-peak, but also a faster decay of this peak as compared with injection of NAADP^+^ alone ([Fig. 5A](#F5){ref-type="fig"} and [Fig. F](#F5){ref-type="fig"} vs. B and G). Similar to the cADPR system, there was an almost complete inhibition of Ins(1,4,5)P~3~-mediated Ca^2+^-release when a desensitizing concentration of NAADP^+^ was coinjected ([Fig. 5C](#F5){ref-type="fig"} and [Fig. H](#F5){ref-type="fig"}). Coinjection of an optimal stimulating concentration of NAADP^+^, together with Ins(1,4,5)P~3~, resulted in a high initial Ca^2+^-peak ([Fig. 5D](#F5){ref-type="fig"} and [Fig. I](#F5){ref-type="fig"}) that was comparable to the peak observed in response to injection of NAADP^+^ alone ([Fig. 5B](#F5){ref-type="fig"} and [Fig. C](#F5){ref-type="fig"}), whereas much less oscillatory activity of the cells after the initial peak was observed ([Fig. 5D](#F5){ref-type="fig"} and [Fig. I](#F5){ref-type="fig"}) as compared with Ins(1,4,5)P~3~ alone ([Fig. 5E](#F5){ref-type="fig"} and [Fig. J](#F5){ref-type="fig"}). These data also indicate that the Ins(1,4,5)P~3~/Ca^2+^-release system requires a functional nondesensitized NAADP^+^/Ca^2+^-release system. Moreover, a part of the Ca^2+^-signal observed in response to microinjection of NAADP^+^ alone appears to be mediated by Ins(1,4,5)P~3~ ([Fig. 5A](#F5){ref-type="fig"}, [Fig. F](#F5){ref-type="fig"}, [Fig. B](#F5){ref-type="fig"}, and [Fig. G](#F5){ref-type="fig"}). This may be explained by the coagonistic effect of Ca^2+^ released by NAADP^+^, which then acts together with basal Ins(1,4,5)P~3~ at the InsP~3~-R; this coagonistic effect of Ca^2+^ at the InsP~3~-R has been demonstrated previously ([Bezprozvanny et al. 1991](#Bezprozvannyetal1991){ref-type="bib"}).

Both the Ins(1,4,5)P~3~/Ca^2+^- and the cADPR/Ca^2+^-release systems have been published to be essential parts of the Ca^2+^-signaling machinery of T cells upon stimulation of the TCR/CD3 complex ([Jayaraman et al. 1995](#Jayaramanetal1995){ref-type="bib"}; [Guse et al. 1999](#Guseetal1999){ref-type="bib"}). Since the data described above indicate that a functional NAADP^+^/Ca^2+^-release system is essential for both Ins(1,4,5)P~3~- and cADPR-mediated Ca^2+^-release, we investigated the effect of NAADP^+^ on Ca^2+^-signaling mediated by anti-CD3 mAb OKT3 ([Fig. 6](#F6){ref-type="fig"}). Microinjection of 50 nM NAADP^+^ before stimulation of the cells by extracellular addition of OKT3 did not significantly change the OKT3-mediated Ca^2+^-signal ([Fig. 6A](#F6){ref-type="fig"} and [Fig. B](#F6){ref-type="fig"}). However, there was a dramatic inhibition of OKT3-mediated Ca^2+^-signaling when a desensitizing concentration of NAADP^+^ was microinjected before stimulation by OKT3 ([Fig. 6](#F6){ref-type="fig"} C).

Discussion
==========

The main findings of this report are: a dose-dependent and specific effect of NAADP^+^ in T cell Ca^2+^-signaling; the strict dependence of both Ins(1,4,5)P~3~- and cADPR-mediated Ca^2+^-release upon a functional NAADP^+^/Ca^2+^-release system; and inhibition of Ca^2+^-signaling mediated by ligation of the TCR/CD3 complex by prior self inactivation of the NAADP^+^/Ca^2+^-release system.

In sea urchin eggs, Ca^2+^-release by NAADP^+^ was half-maximal between 16 and 30 nM, and showed saturation between ∼100 and 400 nM ([Chini et al. 1995](#Chinietal1995){ref-type="bib"}; [Lee and Aarhus 1995](#LeeandAarhus1995){ref-type="bib"}). In ascidian oocytes and mouse pancreatic acinar cells, effective concentrations between 10 and 50 nM were observed ([Albrieux et al. 1998](#Albrieuxetal1998){ref-type="bib"}; [Cancela et al. 1999](#Cancelaetal1999){ref-type="bib"}), although in brain microsomes 1 μM NAADP^+^ was necessary ([Bak et al. 1999](#Baketal1999){ref-type="bib"}). These data fit very well to our current data in Jurkat T cells, the first human cell system where an effect of NAADP^+^ is reported. Ca^2+^-mobilizing concentrations were in the range between 10 and 100 nM ([Fig. 1](#F1){ref-type="fig"} and [Fig. 2](#F2){ref-type="fig"}), whereas at concentrations ≥1 μM, partial or complete self inactivation was observed ([Fig. 1](#F1){ref-type="fig"} and [Fig. 2](#F2){ref-type="fig"}).

The self inactivation properties of the NAADP^+^/Ca^2+^-release system, at least in sea urchin eggs, appear to be unique as compared with the known Ca^2+^-mobilizing second messengers, Ins(1,4,5)P~3~ and cADPR ([Aarhus et al. 1996](#Aarhusetal1996){ref-type="bib"}; [Genazzani et al. 1996](#Genazzanietal1996){ref-type="bib"}). Especially the fact that subthreshold concentrations of NAADP^+^ (2 to 4 nM) almost completely inhibited subsequent Ca^2+^-release by a high concentration of NAADP^+^ ([Aarhus et al. 1996](#Aarhusetal1996){ref-type="bib"}; [Genazzani et al. 1996](#Genazzanietal1996){ref-type="bib"}) indicates that activation of the NAADP^+^/Ca^2+^-release system followed by its rapid inactivation can supply the cell with a short pulse of elevated Ca^2+^ only, and that the basal endogenous concentration of NAADP^+^ must be below a concentration that would permanently inactivate the system, e.g., in sea urchin eggs below 0.1 nM ([Aarhus et al. 1996](#Aarhusetal1996){ref-type="bib"}) or even less ([Genazzani et al. 1996](#Genazzanietal1996){ref-type="bib"}). Data in mammalian cell types, pancreatic acinar cells ([Cancela et al. 1999](#Cancelaetal1999){ref-type="bib"}), and T cells, however, indicate that low concentrations of NAADP^+^ do not substantially self-inactivate the system, e.g., microinjections of 10 nM NAADP^+^ in the majority of cases stimulated long-lasting trains of low-amplitude Ca^2+^-spikes in T cells ([Fig. 1](#F1){ref-type="fig"} E), and infusion of 50 nM NAADP^+^ into acinar cells evoked sustained Ca^2+^-spiking ([Cancela et al. 1999](#Cancelaetal1999){ref-type="bib"}).

To completely unravel the role of NAADP^+^, mainly to verify (or to falsify) its status as a second messenger, measurement of the endogenous concentration of NAADP^+^ would be helpful. However, regarding the theoretically expected concentrations of ≤0.1 nM in unstimulated cells and 50--100 nM NAADP^+^ in stimulated cells, it might be very difficult to develop an analytical system to measure these low concentrations. Our recently developed HPLC systems for the mass determination of Ins(1,4,5)P~3~ ([Guse et al. 1995](#Guseetal1995){ref-type="bib"}) and cADPR (da Silva et al. 1998) require 0.5--1 × 10^8^ cells per sample to measure these compounds in the low micromolar range. To measure basal NAADP^+^ concentrations a 1,000-fold more sensitive analytical method would be required. Potential methods to achieve this may include labeling of NAADP^+^ by a fluorescent dye (pre- or postcolumn derivatization) combined with a very sensitive fluorescence detector, e.g., laser-induced fluorescence detection ([Rahavendran and Karnes 1993](#RahavendranandKarnes1993){ref-type="bib"}). Alternatively, a competitive protein binding assay based on a high affinity binding protein for NAADP^+^ may also be sufficient.

As discussed above, regarding the NAADP^+^/Ca^2+^-release system, there are similarities between mouse pancreatic acinar cells and human T cells, e.g., a very similar dose-response relationship for NAADP^+^, and the fact that self inactivation of the NAADP^+^/Ca^2+^-release renders both cell types insensitive to physiological stimulation. However, there are also at least three clear differences between the two cell systems: inhibition of either the cADPR/Ca^2+^-release system or the Ins(1,4,5)P~3~/Ca^2+^-release system in pancreatic acinar cells completely blocked NAADP^+^-mediated Ca^2+^-signaling ([Cancela et al. 1999](#Cancelaetal1999){ref-type="bib"}), whereas similar inhibition protocols were without or almost without effect in T cells; self inactivation of the NAADP^+^/Ca^2+^-release system did not influence Ca^2+^-signaling mediated by infusion of cADPR or Ins(1,4,5)P~3~ in acinar cells ([Cancela et al. 1999](#Cancelaetal1999){ref-type="bib"}), whereas in T cells such self-inactivation of the NAADP^+^/Ca^2+^-release system almost completely inhibited subsequent signaling by cADPR or Ins(1,4,5)P~3~; and in acinar cells, the sustained phase of Ca^2+^-spiking induced by infusion of cADPR could be blocked by the Ins(1,4,5)P~3~ antagonist heparin ([Thorn et al. 1994](#Thornetal1994){ref-type="bib"}), whereas in T cells there was no effect of the Ins(1,4,5)P~3~ antagonist, Ins(1,4,6)PS~3~, on cADPR-mediated Ca^2+^-signaling ([Guse et al. 1997](#Guseetal1997){ref-type="bib"}).

Using the data obtained from pancreatic acinar cells, [Petersen and Cancela 1999](#PetersenandCancela1999){ref-type="bib"} developed a model with the following sequence of events: stimulation of acinar cells by the brain--gut peptide, cholecystokinin, in first instance elevates NAADP^+^ to nanomolar concentrations. Ca^2+^ released by NAADP^+^ then serves as a trigger for the Ca^2+^-induced Ca^2+^-release mechanism at the RyR. This mechanism, in addition to the stimulatory effect of cADPR on RyR, then amplifies the Ca^2+^-signal. The increased \[Ca^2+^\]~i~ in concert with Ins(1,4,5)P~3~ then releases more Ca^2+^ via the InsP~3~-R ([Petersen and Cancela 1999](#PetersenandCancela1999){ref-type="bib"}). Only this last element is measurable as a Ca^2+^-spike, whereas the trigger and amplifier element, provided by NAADP^+^ and the Ca^2+^-induced Ca^2+^-release mechanism modulated by cADPR, appear to be too small to be detected by patch clamp measurements of the Ca^2+^-dependent currents ([Petersen and Cancela 1999](#PetersenandCancela1999){ref-type="bib"}).

In contrast to acinar cells, in Jurkat T cells NAADP^+^ produced a substantial Ca^2+^-spike, even if cADPR- and Ins(1,4,5)P~3~-antagonists were present ([Fig. 4A](#F4){ref-type="fig"} and [Fig. F](#F4){ref-type="fig"}, and [Fig. 5A](#F5){ref-type="fig"} and [Fig. F](#F5){ref-type="fig"}). The second main difference to acinar cells was that in Jurkat T cells, Ca^2+^-signaling by cADPR and Ins(1,4,5)P~3~ depended on a functional NAADP^+^/Ca^2+^-release system ([Fig. 4C](#F4){ref-type="fig"} and [Fig. H](#F4){ref-type="fig"}, and [Fig. 5C](#F5){ref-type="fig"} and [Fig. H](#F5){ref-type="fig"}). Although two different methods were used to detect the Ca^2+^-spikes: patch clamp measurements of the Ca^2+^-dependent currents vs. single cell Ca^2+^ imaging using Fura2-loaded cells, this is unlikely to be the reason for the differences observed. Thus, the model developed for the acinar cells ([Petersen and Cancela 1999](#PetersenandCancela1999){ref-type="bib"}) needs some modification to fit to the data obtained in Jurkat T cells. In accordance with the acinar cell model, NAADP^+^ appears to act first in sequence providing trigger-calcium needed for the two other Ca^2+^-release systems. Because of the experimental difficulties to measure nanomolar concentrations of NAADP^+^ in cells as discussed above, it is unclear whether NAADP^+^ concentrations in fact do increase upon stimulation, or whether NAADP^+^ stays unaltered in the low nanomolar range keeping the T cell in an excitable state. Experimental evidence for the latter may be obtained by high temporal and spatial resolution Ca^2+^ imaging experiments in Jurkat T cells; preliminary data indicate a basal Ca^2+^-signaling activity of very low amplitude in nonstimulated cells (Guse, A.H., and S. Heidbrink, unpublished results). However, trigger-calcium provided by NAADP^+^ further acts in concert with Ins(1,4,5)P~3~, which is rapidly, but transiently, formed in the first minutes of T cell activation ([Brattsand et al. 1990](#Brattsandetal1990){ref-type="bib"}; [Ng et al. 1990](#Ngetal1990){ref-type="bib"}), and then with cADPR, which is elevated during the sustained phase of T cell Ca^2+^-signaling ([Guse et al. 1999](#Guseetal1999){ref-type="bib"}).

However, despite these differences between acinar and T cells the dependence of cholecystokinin receptor--mediated Ca^2+^-signaling on a Ca^2+^-trigger supplied by an initial NAADP^+^-mediated Ca^2+^-release event to integrate the Ca^2+^-amplifier, cADPR, and the Ca^2+^-oscillator, Ins(1,4,5)P~3~ ([Petersen and Cancela 1999](#PetersenandCancela1999){ref-type="bib"}), exactly mirrors the situation observed in Jurkat T cells. As shown in [Fig. 6](#F6){ref-type="fig"}, if the NAADP^+^/Ca^2+^-release system was inactivated by high NAADP^+^ concentrations subsequent quasiphysiological stimulation of the T cell by anti-CD3 mAb did not result in any Ca^2+^-signaling. This result is in complete accordance with the inhibition of cADPR- or Ins(1,4,5)P~3~-mediated Ca^2+^-signaling by coinjection of NAADP^+^ ([Fig. 4C](#F4){ref-type="fig"} and [Fig. H](#F4){ref-type="fig"}, and [Fig. 5C](#F5){ref-type="fig"} and [Fig. H](#F5){ref-type="fig"}) since Ca^2+^-signaling in T cells critically depends on these two second messengers ([Jayaraman et al. 1995](#Jayaramanetal1995){ref-type="bib"}; [Guse et al. 1999](#Guseetal1999){ref-type="bib"}).

More generalized, if the NAADP^+^/Ca^2+^-release system acts as the Ca^2+^-providing trigger, the complex behavior of activation and inactivation opens a multitude of regulatory possibilities: simply by changing their endogenous NAADP^+^ concentration cells might regulate the status of the NAADP^+^/Ca^2+^-release system; e.g., by increasing NAADP^+^ the NAADP^+^/Ca^2+^-release system will become inactivated, and Ca^2+^-signaling will in turn be completely unresponsive. For T-lymphocytes, such behavior of unresponsiveness to antigenic or mitogenic stimulation is well known as anergy ([Jenkins et al. 1987](#Jenkinsetal1987){ref-type="bib"}); however, it is less clear which intracellular mechanism is responsibly involved. Our data indicate that the NAADP^+^/Ca^2+^-release system with its complex inactivation/activation properties might be such a mechanism underlying anergy in T cells.

From an evolutionary point of view, it is of particular interest that both a very similar dose-response relationship and the self inactivation property of the NAADP^+^/Ca^2+^-release have been conserved between sea urchin eggs, ascidian oocytes, and higher eukaryotic cells from pancreas and lymphocytes. This indicates that these two characteristic features are of outstanding importance for the regulation of intracellular Ca^2+^-signaling in general. One of the important future aspects will be the identification of the molecular target for NAADP^+^. In addition to the model for pancreatic acinar cells ([Cancela et al. 1999](#Cancelaetal1999){ref-type="bib"}; [Petersen and Cancela 1999](#PetersenandCancela1999){ref-type="bib"}) in which a separate NAADP^+^ receptor has been suggested, it might also be possible that NAADP^+^ acts as a comessenger at the known intracellular Ca^2+^-release channels, the Ins(1,4,5)P~3~ receptor and/or the RyR. Along these lines, the fluorescent 1,N^6^-etheno-NAADP^+^ has been shown to release Ca^2+^ in sea urchin eggs (Lee and Arhus, 1998), and thus, may serve as a tool to identify the receptor for NAADP^+^.
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*Abbreviations used in this paper:* \[Ca^2+^\]~i~, intracellular Ca^2+^ concentration; cADPR, cyclic ADP-ribose; Ins(1,4,5)P~3~, [d]{.smallcaps}-*myo*-inositol 1,4,5-trisphosphate; InsP~3~-R, Ins(1,4,5)P~3~ receptor; Ins(1,4,6)PS~3~, [d]{.smallcaps}-*myo*-inositol 1,4,6-trisphosphorothioate; NAADP^+^, nicotinic acid adenine dinucleotide phosphate; NADP^+^, nicotinamide adenine dinucleotide phosphate; RyR, ryanodine receptor(s); TCR/CD3, T cell receptor/CD3.

![Concentration-response curves of Ca^2^+ signals in single intact T-lymphocytes microinjected with NAADP^+^. Jurkat T-lymphocytes were loaded with Fura2/AM and Ca^2+^ was measured as detailed in Materials and Methods. Cells were injected as described in Materials and Methods in the presence of 1 mM extracellular Ca^2+^. Data are presented as overlays of single tracings of individual cells (left). The right shows the corresponding averages from these measurements (number of cells displayed, *n* = 5--17). As a control, vehicle buffer without NAADP^+^ was injected (A and B). The time points of microinjection are indicated by arrows.](JCB0004093.f1){#F1}

![NADP^+^ does not mediate Ca^2+^-signaling. Jurkat T-lymphocytes were loaded with Fura2/AM and ratiometric Ca^2+^ imaging, and parallel microinjection in the presence of 1 mM extracellular Ca^2+^ was carried out as detailed under Materials and Methods. Cells were injected with 50 nM NAADP^+^ (A) or NADP^+^ (B). Shown are the averages from 13 (A) and 5 (B) cells. The time points of microinjection are indicated by arrows.](JCB0004093.f3){#F3}

![Dose-response curve for NAADP^+^ in Jurkat T cells. Data from [Fig. 1](#F1){ref-type="fig"} are shown as mean values (*n* = 5--17) from time point 80 s (Ca^2+^-peak; A) or 400 s (Ca^2+^-plateau; B).](JCB0004093.f2){#F2}

![Influence of Ins(1,4,5)P~3~ and its antagonist Ins(1,4,6)PS~3~ on NAADP^+^-mediated Ca^2+^-signaling. Jurkat T-lymphocytes were loaded with Fura2/AM, and ratiometric Ca^2+^ imaging and parallel microinjection in the presence of 1 mM extracellular Ca^2+^ was carried out as detailed under Materials and Methods. Left, Overlays of single tracings of individual cells after injection (A--E); right, demonstrates the corresponding averages from these overlays (F--J). Shown are: A/F, coinjection of NAADP^+^ (50 nM) and Ins(1,4,6)PS~3~ (40 μM; *n* = 7); B/G, injection of NAADP^+^ (50 nM; *n* = 10); C/H, coinjection of NAADP^+^ (10 μM) and Ins(1,4,5)P~3~ (4 μM; *n* = 9); D/I, coinjection of NAADP^+^ (50 nM) and Ins(1,4,5)P~3~ (4 μM; *n* = 3); and E/J injection of Ins(1,4,5)P~3~ (4 μM; *n* = 8).](JCB0004093.f5){#F5}

![Influence of cADPR and its antagonist 8-OCH~3~-cADPR on NAADP^+^-mediated Ca^2+^-signaling. Jurkat T-lymphocytes were loaded with Fura2/AM, and ratiometric Ca^2+^ imaging and parallel microinjection in the presence of 1 mM extracellular Ca^2+^ was carried out as detailed under Materials and Methods. Left, Overlays of single tracings of individual cells after injection (A--E); right, demonstrates the corresponding averages from these overlays (F--J). Shown are (*n* = number of experiments): A/F, coinjection of NAADP (50 nM) and 8-OCH~3~-cADPR (100 μM; *n* = 7); B/G, injection of NAADP^+^ (50 nM, *n* = 10); C/H, coinjection of NAADP^+^ (10 μM) and cADPR (10μM; *n* = 7); D/I, coinjection of NAADP^+^ (50 nM) and cADPR (10 μM; *n* = 5); and E/J, injection of cADPR (10 μM, *n* = 5).](JCB0004093.f4){#F4}

![Effect of NAADP^+^ on OKT3-induced Ca^2+^-signaling in single Jurkat T-lymphocytes. Jurkat T-lymphocytes were loaded with Fura2/AM, and ratiometric Ca^2+^ imaging and parallel microinjection in the presence of 1 mM extracellular Ca^2+^ was carried out as detailed under Materials and Methods. The cells were injected with different concentrations of NAADP^+^ and then OKT3 (10 μg/ml) was added. Injection of intracellular buffer (A), NAADP^+^ (50 nM \[B\] and 10 μM \[C\]), and addition of OKT3 is indicated by arrows. Data are presented as a typical tracing from one individual cell; for each condition at least three experiments were carried out.](JCB0004093.f6){#F6}
